
JNM
@journalofnucmed
The journal of the Society of Nuclear Medicine and Molecular Imaging. Clinical investigations, basic science reports, continuing education articles and more.
ID: 1316406812942503938
https://jnm.snmjournals.org/ 14-10-2020 15:54:07
728 Tweet
3,3K Takipçi
163 Takip Edilen



Theranostics for neuroblastoma: Making molecular radiotherapy work better. ow.ly/sHTA50VuLYN #NuclearMedicine #Theranostics #RPTherapy #Neuroblastoma Leona Knox🎗 Sally George


Funding reductions threaten the future of medical innovation. ow.ly/3R5x50VSPsX #NuclearMedicine #MolecularImaging #Theranostics @Czernin_Johannes Thomas Hope @ProKHerrmann Sharmila Dorbala @Calais_Jeremie Irène Buvat Ramsey Badawi


From stabilization to depletion: Molecular imaging to measure therapeutic response in ATTR-CA. ow.ly/s9Zk50VuM4s #MolecularImaging #NuclearMedicine #Amyloidosis Sharmila Dorbala Shilpa Vijayakumar


HER2 PET imaging can detect HER2-low and HER2-positive lesions in metastatic #BreastCancer patients, allowing for better select patients for T-DXd and other HER2-targeted therapies. ow.ly/utFq50VSPz4 #NuclearMedicine Jason Lewis Radiochem MSK Audrey Mauguen Josh Drago



Can an automated ¹⁸F-FET PET segmentation network trained on brain tumor data generalize to an external cohort of patients with #glioblastoma? ow.ly/ZaZk50VEW1C #NuclearMedicine #PETscan Philipp Lohmann Norbert Galldiks Robin Gutsche Nicholas Bucknell


An interesting read: Self-citation among highly cited #NuclearMedicine and #MedicalImaging researchers. ow.ly/wQPp50VuM9s Obada Al-leimon Malik Juweid

Prevalence of persistent cardiovascular and pulmonary abnormalities on PET/MRI and DECT imaging in long COVID patients. ow.ly/U3J350VSPG1 #NuclearMedicine #PETscan #LongCovid Munir Ghesani Miriam Merad, MD, PhD


²¹²Bi-MAA is an effective therapy for mouse melanoma and could be a radiopharmaceutical to treat solid tumors. ow.ly/snXP50VEW6t #NuclearMedicine #RPTherapy #Melanoma Nathan Kauffman


Computational nuclear oncology toward precision #RPTherapy: Current tools, techniques, & uncharted territories. ow.ly/7rGQ50VuMcT Arman Rahmim Babak Saboury Joyita Dutta Prof Geoff Currie AM Abhinav Jha, Ph.D. Carlos Uribe 🧬⚛️ Julia Brosch-Lenz Emilie Roncali


Incorporating semiquantitative PET measures early after CAR T infusion imaging may help clinicians identify high-risk patients sooner. ow.ly/pb2a50VKLiu #NuclearMedicine #PETscan #Lymphoma Andrea Farolfi prof. Stefano Fanti Cristina Nanni


Is long–axial-field-of-view PET/CT cost-effective? An international health–economic analysis. ow.ly/bYyT50VKLo9 #NuclearMedicine #PETscan #MedicalImaging BC Cancer UBC Radiology prof. Stefano Fanti Riccardo Mei


FDA approval of 18F-flurpiridaz for PET: Stepping into a new era of myocardial perfusion imaging? ow.ly/RZab50VKLtE #MolecularImaging #NuclearMedicine #CoronaryArteryDisease Thomas H Schindler WashUMedMIR Ronald G. Schwartz Marcelo Di Carli Venk Murthy MD PhD Sharmila Dorbala

Letter to the Editor: FDA reconsiders rules around radiation dosimetry for first-in-human studies of investigational PET radiopharmaceuticals. ow.ly/77B850VKLzG #PETImaging #NuclearMedicine #Dosimetry ScottLab Coalition of PET Drug Manufacturers Sally Schwarz Marianna Dakanali

EDA-FN imaging with 89Zr-DFO-F8 exhibited powerful tumor delineation in preclinical triple-negative breast cancer models. ow.ly/oHFB50VKLFb #NuclearMedicine #MolecularImaging #TNBC Memorial Sloan Kettering Cancer Center Justin Hachey Jason Lewis Radiochem MSK


Convection-enhanced delivery of ¹²⁴I-Omburtamab is a novel approach for delivering radiolabeled therapies into brain-stem tumors. Read more: ow.ly/7jLp50VSPO3 #NuclearMedicine #Theranostics #BrainCancer Mark Souweidane, MD Alexandra Giantini Larsen, MD

